Finally, triple-coated anti-tetraspanin (CD9, CD63 and CD81) beads and anti-CD61 beads were applied for EV IP, using merely 500 μL of human plasma obtained from 14 healthy donors and 14 early-stage NSCLC patients. Here, CD63 is linked to non-small cell lung carcinoma.